Table 10 Late adverse events recorded after concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: genitourinary symptoms
Grade | Frequency/urgency | Dysuria | Incontinence | Retention | Hematuria | Highest during follow-up | Highest at last follow-up | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L | L* | L | L* | L | L* | L | L* | L | L* | L | L* | L | L* | ||
Cohort 1 | 1 | 3 | 1 | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 1 | 5 | 3 | 2 | 1 |
2 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 1 | |
3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cohort 2 | 1 | 3 | 1 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 6 | 3 | 4 | 2 |
2 | 2 | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | |
3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |